Costs of inpatient care and out-of-pocket payments for COVID-19 patients: A systematic review
- PMID: 37729207
- PMCID: PMC10511135
- DOI: 10.1371/journal.pone.0283651
Costs of inpatient care and out-of-pocket payments for COVID-19 patients: A systematic review
Abstract
Objective: To identify the costs of hospital care for patients with COVID-19 and the amount of out-of-pocket payments.
Methods: We conducted a systematic review using Scopus and WEB OF SCIENCE and PubMed databases in April 5, 2022 and then updated in January 15, 2023. English articles with no publication year restrictions were included with study designs of cost-of-illness (COI) studies, cost analyses, and observational reports (cross-sectional studies and prospective and retrospective cohorts) that calculated the patient-level cost of care for COVID-19. Costs are reported in USD with purchasing power parity (PPP) conversion in 2020. The PROSPERO registration number is CRD42022334337.
Results: The results showed that the highest total cost of hospitalization in intensive care per patient was 100789 USD, which was reported in Germany, and the lowest cost was 5436.77 USD, which was reported in Romania. In the present study, in the special care department, the highest percentage of total expenses is related to treatment expenses (42.23 percent), while in the inpatient department, the highest percentage of total expenses is related to the costs of hospital beds/day of routine services (39.07 percent). The highest percentage of out-of-pocket payments was 30.65 percent, reported in China, and the lowest percentage of out-of-pocket payments was 1.12 percent, reported in Iran. The highest indirect cost per hospitalization was 16049 USD, reported in USA, and the lowest was 449.07 USD, reported in India.
Conclusion: The results show that the COVID-19 disease imposed a high cost of hospitalization, mainly the cost of hospital beds/day of routine services. Studies have used different methods for calculating the costs, and this has negatively impacted the comparability costs across studies. Therefore, it would be beneficial for researchers to use a similar cost calculation model to increase the compatibility of different studies. Systematic review registration: PROSPERO CRD42022334337.
Copyright: © 2023 Gholipour et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures






Similar articles
-
Inpatient Care Costs of COVID-19 in South Africa's Public Healthcare System.Int J Health Policy Manag. 2022 Aug 1;11(8):1354-1361. doi: 10.34172/ijhpm.2021.24. Epub 2021 Apr 25. Int J Health Policy Manag. 2022. PMID: 33949817 Free PMC article.
-
Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China.BMC Health Serv Res. 2023 Jan 26;23(1):89. doi: 10.1186/s12913-023-09078-3. BMC Health Serv Res. 2023. PMID: 36703175 Free PMC article.
-
The Economic Burden of Severe Acute Malnutrition with Complications: A Cost Analysis for Inpatient Children Aged 6 to 59 Months in Northern Senegal.Nutrients. 2024 Jul 10;16(14):2192. doi: 10.3390/nu16142192. Nutrients. 2024. PMID: 39064635 Free PMC article.
-
Tobacco Cost of Illness Studies: A Systematic Review.Nicotine Tob Res. 2020 Apr 17;22(4):458-465. doi: 10.1093/ntr/ntz038. Nicotine Tob Res. 2020. PMID: 30874290
-
What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review.Support Care Cancer. 2020 Feb;28(2):439-449. doi: 10.1007/s00520-019-05101-8. Epub 2019 Oct 28. Support Care Cancer. 2020. PMID: 31656987
Cited by
-
Economic impact and disease burden of COVID-19 in a tertiary care hospital: A three-year analysis.PLoS One. 2025 May 13;20(5):e0323200. doi: 10.1371/journal.pone.0323200. eCollection 2025. PLoS One. 2025. PMID: 40359203 Free PMC article.
-
Strategies to Reduce Hospital Length of Stay: Evidence and Challenges.Medicina (Kaunas). 2025 May 20;61(5):922. doi: 10.3390/medicina61050922. Medicina (Kaunas). 2025. PMID: 40428880 Free PMC article. Review.
-
Out-of-pocket pharmaceutical expenditure and potential misuse of public resources - analysis in the Italian context.Cost Eff Resour Alloc. 2025 Apr 17;23(1):17. doi: 10.1186/s12962-025-00619-7. Cost Eff Resour Alloc. 2025. PMID: 40247361 Free PMC article.
-
Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide.Appl Health Econ Health Policy. 2025 Mar;23(2):231-251. doi: 10.1007/s40258-024-00935-8. Epub 2025 Jan 20. Appl Health Econ Health Policy. 2025. PMID: 39832090
-
The First Two Years of COVID-19 Hospitalization Characteristics and Costs: Results from the National Discharge Registry.Healthcare (Basel). 2024 May 7;12(10):958. doi: 10.3390/healthcare12100958. Healthcare (Basel). 2024. PMID: 38786370 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous